Report Description

Global nanomedicine market stood at USD151259.26 million in 2021 and is expected to grow at an impressive rate of 8.28% during the forecast period. This can be related to the desire to find medications with fewer side effects and lower costs than standard treatments, particularly for cancer. Furthermore, the growing acceptance of nanomedicine in various applications is expected to boost the nanomedicine market forward. The increase in government support and financing is expected to bolster the nanomedicine market's expansion further. On the other side, the lengthy approval process is expected to stifle the nanomedicine market's growth over the forecast period. Furthermore, the demand for nanomedicine in treating neurological illnesses is expected to propel market expansion tremendously. In neurological disorders such as Alzheimer's disease, Parkinson's disease, or tumors, insufficient absorption of oral drug delivery would pave the door for nanomedicine expansion. The market will expand as demand for gold, lipid, and biodegradable nanoparticles for treating complicated CNS illnesses grows. The industry's growth will be accelerated by technological advances and a prospective product pipeline based on nano molecules. However, the nanomedicine industry's success may be hampered by strict regulatory standards and a lengthy clearance process.

Sudden Outbreak & Spread of COVID-19 Affects Market Growth

The COVID-19 pandemic has had a severe influence on many economies throughout the world. The epidemic had infected over 523 million individuals in over 100 countries as of May 25, 2022. Nanotechnology opens new possibilities for developing revolutionary COVID-19 and other viral infection prevention, diagnosis, and treatment procedures. COVID-19 was managed by creating nano-based materials for treatments and vaccine development, such as disinfectants, personal protective equipment, diagnostic systems, and nanocarrier systems.

Advancing Technologies for Drug Delivery Supports Market Growth

Nano-drug delivery systems (NDDSs) are a type of nanomaterial that can improve drug stability and water solubility, increase cycle time, boost target cell or tissue absorption rate, and limit enzyme degradation, all while improving drug safety and effectiveness. Compared to standard drug delivery systems, NDDSs can be delivered via inhalation, oral administration, or intravenous injection and have a higher bioavailability. As a result, the need for nanomedicine is expanding.

Advantages of Nanomedicine in Various Healthcare Applications to Drive Nanomedicine Market

Nanotechnology has been used to improve the absorbability of nanotherapeutics. Drugs absorbed too quickly and eliminated from the body as waste before treatment may be effective. Nanomedicine can potentially extend the time a drug is active in the body. Nanotechnology has also been used in diagnostics due to nanomaterials' unique optical, magnetic, and structural capabilities, making them ideal for diagnostic imaging and tumor detection. The market for nanomedicines is growing due to the various applications of nanomedicines in healthcare.


Click here to download the sample

Market Segmentation

The nanomedicine market is segmented based on nanomolecule type, nanoparticles type, by application, disease indication, region and company. Based on nanomolecule type, the nanomedicine market can be bifurcated into nanoparticles, nanoshells, nanodevices, nanotubes. Based on nanoparticles type, it can be further categorized into polymer based, lipid based, nanocrystals, inorganic, and others. Based on applications, nanomedicine market can be segmented into drug delivery, vaccines, diagnostic imaging, regenerative medicine, others. Based on disease indication, it can be split into oncological diseases, infectious diseases, orthopedic diseases, cardiovascular diseases, others. Regionally, the nanomedicine market can be categorized into North America, Asia Pacific, Europe, South America, and Middle East & Africa. North America dominates the overall Nanomedicine market with United States having the biggest market.

Company Profiles

Major companies in the market are Pfizer Inc., Janssen Pharmaceuticals, Sanofi S.A., Amgen Inc., Moderna, Inc., Novo Nordisk A/S., Genentech, Inc., Celgene Corporation, Vifor Pharma Group, Teva Pharmaceutical Industries Ltd., and others are among the major market players in the nanomedicine market that led the market growth of the global nanomedicine market.

Attribute

Details

Market Size Value in 2021

USD151259.26 million

Revenue Forecast in 2027

USD242655.18 million

United States Market Size Value in 2021

USD26932.37 million

Growth Rate

8.28%

Base Year

2021

Historical Years

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million and CAGR for 2017-2021 and 2022-2027

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

·         Nanomolecule Type

·         Nanoparticle Type

·         Application

·         Disease Indication

Regional Scope

North America; Asia Pacific; Europe, South America; Middle East & Africa

Country Scope

United States; Canada; Mexico; Germany; France; United Kingdom; Italy; Spain; Denmark; China; Japan; India; Australia; South Korea; Malaysia; Vietnam; Brazil; Argentina; Colombia; Turkey; Israel; South Africa; Saudi Arabia; UAE; Kuwait.

Key Companies Profiled

Pfizer Inc., Janssen Pharmaceuticals, Sanofi S.A., Amgen Inc., Moderna, Inc., Novo Nordisk A/S., Genentech, Inc., Celgene Corporation, Vifor Pharma Group, Teva Pharmaceutical Industries Ltd.,

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, global nanomedicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Nanomedicine Market, By Nanomolecule Type:

    • Nanoparticles
    • Nanoshells
    • Nanodevices
    • Nanotubes

·         Nanomedicine Market, By Nanoparticles Type:

    • Polymer-based
    • Lipid-based
    • Nanocrystals
    • Inorganic
    • Others

·         Nanomedicine Market, By Application:

    • Drug Delivery
    • Vaccines
    • Diagnostic Imaging
    • Regenerative Medicine
    • Others
  • Nanomedicine Market, By Disease Indication:
    • Oncological Diseases
    • Infectious Diseases
    • Orthopedic Disorders
    • Cardiovascular Diseases
    • Others
  • Nanomedicine Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Denmark
    • Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Malaysia
      • Vietnam
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • Turkey
      • Israel
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait

 

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global nanomedicine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Nanomedicine Market

5.    Voice of Customer

5.1.  Factors Increasing the demand for Nanomedicine

5.2.  Preference, By Nanomolecule Type

5.3.  Demand for Nanomedicine, By Indication

5.4.  Brand Awareness

6.    Global Nanomedicine Market Outlook

6.1.  Market Size & Forecast

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.   By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)

6.2.1.1.        By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)

6.2.2.    By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)

6.2.3.    By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)

6.2.4.    By Company (2021)

6.2.5.    By Region

6.3.  Market Map

7.    North America Nanomedicine Market Outlook

7.1.  Market Size & Forecast

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.   By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)

7.2.1.1.        By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)

7.2.2.    By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)

7.2.3.    By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)

7.2.4.    By Country

7.3.  North America: Country Analysis

7.3.1.    United States Nanomedicine Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.           By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.           By Nanomolecule Type

7.3.1.2.1.1.               By Nanoparticle Type

7.3.1.2.2.           By Application

7.3.1.2.3.           By Disease Indication

7.3.2.    Canada Nanomedicine Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.           By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.           By Nanomolecule Type

7.3.2.2.1.1.               By Nanoparticle Type

7.3.2.2.2.           By Application

7.3.2.2.3.           By Disease Indication

7.3.3.    Mexico Nanomedicine Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.           By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.           By Nanomolecule Type

7.3.3.2.1.1.               By Nanoparticle Type

7.3.3.2.2.           By Application

7.3.3.2.3.           By Disease Indication

8.    Europe Nanomedicine Market Outlook

8.1.  Market Size & Forecast

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.   By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)

8.2.1.1.        By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)

8.2.2.    By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)

8.2.3.    By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)

8.2.4.    By Country

8.3.  Europe: Country Analysis

8.3.1.    Germany Nanomedicine Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.           By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.           By Nanomolecule Type

8.3.1.2.1.1.               By Nanoparticle Type

8.3.1.2.2.           By Application

8.3.1.2.3.           By Disease Indication

8.3.2.    France Nanomedicine Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.           By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.           By Nanomolecule Type

8.3.2.2.1.1.               By Nanoparticle Type

8.3.2.2.2.           By Application

8.3.2.2.3.           By Disease Indication

8.3.3.    United Kingdom Nanomedicine Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.           By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.           By Nanomolecule Type

8.3.3.2.1.1.               By Nanoparticle Type

8.3.3.2.2.           By Application

8.3.3.2.3.           By Disease Indication

8.3.4.    Italy Nanomedicine Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.           By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.           By Nanomolecule Type

8.3.4.2.1.1.               By Nanoparticle Type

8.3.4.2.2.           By Application

8.3.4.2.3.           By Disease Indication

8.3.5.    Spain Nanomedicine Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.           By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.           By Nanomolecule Type

8.3.5.2.1.1.               By Nanoparticle Type

8.3.5.2.2.           By Application

8.3.5.2.3.           By Disease Indication

8.3.6.    Denmark Nanomedicine Market Outlook

8.3.6.1.        Market Size & Forecast

8.3.6.1.1.           By Value

8.3.6.2.        Market Share & Forecast

8.3.6.2.1.           By Nanomolecule Type

8.3.6.2.1.1.               By Nanoparticle Type

8.3.6.2.2.           By Application

8.3.6.2.3.           By Disease Indication

9.    Asia Pacific Nanomedicine Market Outlook

9.1.  Market Size & Forecast

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.   By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)

9.2.1.1.        By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)

9.2.2.    By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)

9.2.3.    By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)

9.2.4.    By Country

9.3.  Asia Pacific: Country Analysis

9.3.1.    China Nanomedicine Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.           By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.           By Nanomolecule Type

9.3.1.2.1.1.               By Nanoparticle Type

9.3.1.2.2.           By Application

9.3.1.2.3.           By Disease Indication

9.3.2.    Japan Nanomedicine Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.           By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.           By Nanomolecule Type

9.3.2.2.1.1.               By Nanoparticle Type

9.3.2.2.2.           By Application

9.3.2.2.3.           By Disease Indication

9.3.3.    India Nanomedicine Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.           By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.           By Nanomolecule Type

9.3.3.2.1.1.               By Nanoparticle Type

9.3.3.2.2.           By Application

9.3.3.2.3.           By Disease Indication

9.3.4.    Australia Nanomedicine Market Outlook

9.3.4.1.        Market Size & Forecast

9.3.4.1.1.           By Value

9.3.4.2.        Market Share & Forecast

9.3.4.2.1.           By Nanomolecule Type

9.3.4.2.1.1.               By Nanoparticle Type

9.3.4.2.2.           By Application

9.3.4.2.3.           By Disease Indication

9.3.5.    South Korea Nanomedicine Market Outlook

9.3.5.1.        Market Size & Forecast

9.3.5.1.1.           By Value

9.3.5.2.        Market Share & Forecast

9.3.5.2.1.           By Nanomolecule Type

9.3.5.2.1.1.               By Nanoparticle Type

9.3.5.2.2.           By Application

9.3.5.2.3.           By Disease Indication

9.3.6.    Malaysia Nanomedicine Market Outlook

9.3.6.1.        Market Size & Forecast

9.3.6.1.1.           By Value

9.3.6.2.        Market Share & Forecast

9.3.6.2.1.           By Nanomolecule Type

9.3.6.2.1.1.               By Nanoparticle Type

9.3.6.2.2.           By Application

9.3.6.2.3.           By Disease Indication

9.3.7.    Vietnam Nanomedicine Market Outlook

9.3.7.1.        Market Size & Forecast

9.3.7.1.1.           By Value

9.3.7.2.        Market Share & Forecast

9.3.7.2.1.           By Nanomolecule Type

9.3.7.2.1.1.               By Nanoparticle Type

9.3.7.2.2.           By Application

9.3.7.2.3.           By Disease Indication

10. South America Nanomedicine Market Outlook

10.1.             Market Size & Forecast

10.1.1. By Value

10.2.             Market Share & Forecast

10.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)

10.2.1.1.     By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)

10.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)

10.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)

10.2.4. By Country

10.3.             South America: Country Analysis

10.3.1. Brazil Nanomedicine Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Nanomolecule Type

10.3.1.2.1.1.            By Nanoparticle Type

10.3.1.2.2.         By Application

10.3.1.2.3.         By Disease Indication

10.3.2. Argentina Nanomedicine Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Nanomolecule Type

10.3.2.2.1.1.            By Nanoparticle Type

10.3.2.2.2.         By Application

10.3.2.2.3.         By Disease Indication

10.3.3. Colombia Nanomedicine Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Nanomolecule Type

10.3.3.2.1.1.            By Nanoparticle Type

10.3.3.2.2.         By Application

10.3.3.2.3.         By Disease Indication

11. Middle East and Africa Nanomedicine Market Outlook

11.1.             Market Size & Forecast

11.1.1. By Value

11.2.             Market Share & Forecast

11.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)

11.2.1.1.     By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)

11.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)

11.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)

11.2.4. By Country

11.3.             Middle East and Africa: Country Analysis

11.3.1. Turkey Nanomedicine Market Outlook

11.3.1.1.     Market Size & Forecast

11.3.1.1.1.         By Value

11.3.1.2.     Market Share & Forecast

11.3.1.2.1.         By Nanomolecule Type

11.3.1.2.1.1.            By Nanoparticle Type

11.3.1.2.2.         By Application

11.3.1.2.3.         By Disease Indication

11.3.2. Israel Nanomedicine Market Outlook

11.3.2.1.     Market Size & Forecast

11.3.2.1.1.         By Value

11.3.2.2.     Market Share & Forecast

11.3.2.2.1.         By Nanomolecule Type

11.3.2.2.1.1.            By Nanoparticle Type

11.3.2.2.2.         By Application

11.3.2.2.3.         By Disease Indication

11.3.3. South Africa Nanomedicine Market Outlook

11.3.3.1.     Market Size & Forecast

11.3.3.1.1.         By Value

11.3.3.2.     Market Share & Forecast

11.3.3.2.1.         By Nanomolecule Type

11.3.3.2.1.1.            By Nanoparticle Type

11.3.3.2.2.         By Application

11.3.3.2.3.         By Disease Indication

11.3.4. Saudi Arabia Nanomedicine Market Outlook

11.3.4.1.     Market Size & Forecast

11.3.4.1.1.         By Value

11.3.4.2.     Market Share & Forecast

11.3.4.2.1.         By Nanomolecule Type

11.3.4.2.1.1.            By Nanoparticle Type

11.3.4.2.2.         By Application

11.3.4.2.3.         By Disease Indication

11.3.5. UAE Nanomedicine Market Outlook

11.3.5.1.     Market Size & Forecast

11.3.5.1.1.         By Value

11.3.5.2.     Market Share & Forecast

11.3.5.2.1.         By Nanomolecule Type

11.3.5.2.1.1.            By Nanoparticle Type

11.3.5.2.2.         By Application

11.3.5.2.3.         By Disease Indication

11.3.6. Kuwait Nanomedicine Market Outlook

11.3.6.1.     Market Size & Forecast

11.3.6.1.1.         By Value

11.3.6.2.     Market Share & Forecast

11.3.6.2.1.         By Nanomolecule Type

11.3.6.2.1.1.            By Nanoparticle Type

11.3.6.2.2.         By Application

11.3.6.2.3.         By Disease Indication

12. Market Dynamics

12.1.             Drivers

12.2.             Challenges

13. Market Trends and Developments